On a Roll: FDA Calls Sage's Depression Drug a Breakthrough Post author:Sam Post published:February 6, 2018 Post category:BioPharma This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace You Might Also Like Gilead to Unveil New SoCal Facility That Could House Up to 500 Employees August 15, 2017 Kura Oncology To Report Fourth Quarter And Full Year 2016 Financial Results March 7, 2017 Zafgen Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 12, 2017
